BIGG

    Resultados: 14

    Mobocertinib for treating EGFR exon 20 insertion mutation-positive advanced non-small-cell lung cancer after platinum-based chemotherapy

    Evidence-based recommendations on mobocertinib (EXKIVITY) for treating EGFR exon 20 insertion mutation-positive advanced non-small-cell lung cancer after platinum-based chemotherapy in adults. Commercial arrangement There is a simple discount patient access scheme for mobocertinib. NHS organisations ca...

    Screening for Lung Cancer: CHEST guideline and expert panel report

    Chest; (21), 2021
    Low-dose chest CT screening for lung cancer has become a standard of care in the United States, in large part because of the results of the National Lung Screening Trial (NLST). Additional evidence supporting the net benefit of low-dose chest CT screening for lung cancer, and increased experience in mini...

    Executive summary screening for Lung Cancer: Chest guideline and expert panel report

    Chest; (21), 2021
    Low-dose chest CT screening for lung cancer has become a standard of care in the United States, in large part because of the results of the National Lung Screening Trial (NLST). Additional evidence supporting the net benefit of low-dose chest CT screening for lung cancer, and increased experience in mini...

    Screening for Lung Cancer: 10 States, 2017

    Lung cancer is the leading cause of cancer death in the United States; 148,869 lung cancer-associated deaths occurred in 2016 (1). Mortality might be reduced by identifying lung cancer at an early stage when treatment can be more effective (2). In 2013, the U.S. Preventive Services Task Force (USPSTF) re...

    Lung cancer: diagnosis and management

    This guideline covers diagnosing and managing non-small-cell and small-cell lung cancer. It aims to improve outcomes for patients by ensuring that the most effective tests and treatments are used, and that people have access to suitable palliative care and follow-up....

    Prevención y detección temprana de cáncer de pulmón en el primer nivel de atención

    Esta guía aborda aspectos relacionados con la prevención y la detección temprana del cáncer de pulmón en el primer nivel de atención...

    Technical aspects of endobronchial ultrasound-guided transbronchial needle aspiration: CHEST guideline and expert panel report

    Chest; 149 (3), 2016
    BACKGROUND: Endobronchial ultrasound (EBUS) was introduced in the last decade, enabling real-time guidance of transbronchial needle aspiration (TBNA) of mediastinal and hilar structures and parabronchial lung masses. The many publications produced about EBUS-TBNA have led to a better understanding of the...

    SEOM guide to primary and secondary prevention of cancer: 2014

    Clin. transl. oncol; 16 (12), 2014
    PURPOSE: The current incidence of cancer in the world is 14 million cases in 2012, with a mortality rate of 8.2 million in that year. The incidence of cancer in Spain exceeds 215,000 cases a year, and survival rates are the highest when compared to those of our neighbouring countries. Among the reasons f...

    Guía de práctica clínica para para la detección temprana, diagnóstico, estadificación y tratamiento del cáncer de pulmón. Guía completa

    La guía de práctica clínica (GPC) basada en la evidencia incluye los temas de detección temprana, diagnóstico, estadificación, evaluación pre-quirúrgica, tratamiento quirúrgico y oncológico en cáncer de pulmón de células no pequeñas y de tratamiento oncológico en cáncer de células pequeÃ...

    Guía de práctica clínica para para la detección temprana, diagnóstico, estadificación y tratamiento del cáncer de pulmón. Guía para pacientes y cuidadores

    La guía de práctica clínica (GPC) basada en la evidencia incluye los temas de detección temprana, diagnóstico, estadificación, evaluación pre-quirúrgica, tratamiento quirúrgico y oncológico en cáncer de pulmón de células no pequeñas y de tratamiento oncológico en cáncer de células pequeÃ...